4807S-09: VisionGate sputum

CRC 09023: Collaborative Study on Sputum Cytology of Lung-Cancer Patients by the Swedish Cancer Institute and VisionGate, Inc

Type of Study
Cancer (Oncology) - Lung
Location
Swedish Cancer Institute
Short Description

Purpose: The collection of sputum samples to develop a test for early lung cancer detection.

Status
Open to Enrollment
Principal Investigator
Ralph Aye, M.D.
Eligibility Notes
  • Diagnosis of lung cancer
  • No concurrent chemotherapy or radiation therapy
  • No prior chemotherapy or radiation therapy within the last 12 months
  • No removed lung cancer tumor
Phone
(206) 215-3086
Email
CancerResearch@swedish.org